title: Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.
authors.affiliation: The Kennedy Institute of Rheumatology Division, Imperial College London, The Charing Cross Campus, ARC Building, 1 Aspenlea Road, London W6 8LH, UK. b.foxwell@imperial.ac.uk
authors.forename: B
authors.initials: B
authors.lastname: Foxwell
authors.forename: E
authors.initials: E
authors.lastname: Andreakos
authors.forename: F
authors.initials: F
authors.lastname: Brennan
authors.forename: M
authors.initials: M
authors.lastname: Feldmann
authors.forename: C
authors.initials: C
authors.lastname: Smith
authors.forename: M
authors.initials: M
authors.lastname: Conron
mesh_terms: D018501:Antirheumatic Agents / Q000737:chemistry / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D015195:Drug Design; D006801:Humans; D008970:Molecular Weight; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha